Discover the news and events of an experienced Contract Research Organization specialized in Biostatistics and eClinical services to optimize your clinical trials. We are present at numerous conferences in the world! Let’s meet there!
Experts from our industry share their thoughts on 2020 and what trends we may expect in 2021. IDDI’s Chief Commercial Officer, Serge Bodart, gives insight on vulnerabilities and development stemmed from the COVID pandemic: Serge Bodart, chief commercial officer, IDDI […]
Happy Holiday season from the IDDI team and thank you for all your support throughout the year. Wishing you a safe and successful 2021!
Improvements in the treatment of patients with cancer largely depend on clinical trials comparing a new intervention with a previous standard of care. This is not different when it comes to improving adjuvant (postoperative) and neoadjuvant (preoperative) treatment for colorectal […]
Recently, Serge Bodart, our Chief Commercial Officer, shared his insights in PharmaVOICE – Nov./Dec. 2020 on the challenges and opportunities this year’s COVID-19 crisis has brought upon us. Who knew? 2020 will be defined as one of the most tumultuous years […]
IDDI’s Mission to Giving Thanks this Season The Thanksgiving season is the perfect time to thank, support and help those in need! We would like to hear and discuss your needs for your upcoming trials and for every secured […]
NEWSLETTERNOVEMBER 2020CLINICAL TRIAL NEWS BREAKFAST WEBINAR : DRUG DEVELOPMENT IN ONCOLOGY IN THE ERA OF PRECISION MEDICINE 19th NOVEMBER, 2020 : 08:30am – 09:30am (CET) Start your day with an insightful presentation with Christophe Le Tourneau, MD, PhD – Senior […]
Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European country Read Article published in Contemporary Clinical Trials 99 (2020) 106189 Marc Buyse, Chief Scientific Officer IDDI, Corresponding author ABSTRACT: Starting […]
October 20, 2020 — October 23, 2020
Leveraging next gen technologies beyond conventional biomarker drug discovery The emergence of the need for safety and efficacy of a drug subjected to individual patients has made companion diagnostics one of the most sought after topics in the field of […]
November 19, 2020
Drug development in oncology in the era of precision medicine 08:30am – 09:30am (CET), 19th NOVEMBER, 2020 WATCH THE RECORDED WEBINAR HERE Please fill out the below form and we’ll send you the presentation slides, along with a summary of […]
Recently, Erik Falvey, our Senior Director of Business Development, shared his insights during a Q&A session with Medicon Valley Alliance, on key challenges and potentials for oncology related R&D and how operations been affected by the COVID-19 crisis. Q1) Why is […]